US Allocates $50 Million to HP's Microfluidics Semiconductor Fab
The US Department of Commerce has committed up to $50 million to HP for expanding its microfluidics semiconductor fabrication facility …
News
London Biotechnology Show Makes Grand Return to Unveil Cutting-Edge Advances in Health & Medicine
The London Biotechnology Show is set to return for its second edition in 2025, expanding significantly upon the foundation established …
Microbiotica's Microbiome Medicines Progress to Clinical Trials for Melanoma and Ulcerative Colitis
Microbiotica, a UK-based biopharma company specializing in precision microbiome medicines, has received regulatory approvals to start Phase 1b clinical trials …
LG AI Research Introduces EXAONEPath: A Specialized Model for Histopathology Image Analysis
LG AI Research has unveiled EXAONEPath, a pre-trained model designed specifically for the analysis of histopathological images. These images are …
Piramidal's AI: Transforming Neurological Diagnostics by Decoding Brainwaves
The complexity of the human brain, particularly the intricacies captured through electroencephalography (EEG), has long posed challenges in the field …
Marketing Firm Supreme Group Acquires Life Science Specialist BioStrata
Supreme Group has announced the acquisition of BioStrata, a Cambridge-based marketing and public relations agency specializing in the life sciences. …
Vandria Secures $30.7M in Series A to Push Mitophagy Drug into Clinical Trials
Vandria SA, a biotech company focused on mitochondrial therapeutics, has completed its Series A funding round, bringing in $30.7 million …
Eli Lilly's Weight Loss Drug Shows Promise for Diabetes Prevention
Eli Lilly's weight loss drug tirzepatide has shown promising results in reducing the risk of developing Type 2 diabetes in …
FUJIFILM's Subsidiary Unveils £100M Microbial Fermentation Facility in the UK, Tripling Production Capacity
FUJIFILM Diosynth Biotechnologies has opened a new £100 million microbial fermentation manufacturing facility in Billingham, UK, significantly expanding its production …
Blackrock Neurotech Restores ALS Patient's Speech Using Brain-Computer Interface
Blackrock Neurotech has successfully restored speech for an ALS patient through a brain-computer interface (BCI) implant, achieving a communication rate …
NanoViricides Prepares for Phase II Clinical Trial of Broad-Spectrum Antiviral NV-387
NanoViricides, Inc., a clinical-stage biopharmaceutical company, is advancing its lead drug candidate, NV-387, towards a Phase II clinical trial. NV-387, …
Walgreens Partners with U.S. Government to Advance Decentralized Clinical Trials
Walgreens has entered into a partnership with the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. …